The efficacy and potential mechanism of cnidium lactone to inhibit osteoclast differentiation
Source abstract
Abstract
Cnidium lactone is effective in the maintenance of bone mass in various osteoporosis models; however, the precise molecular mechanisms are not understood. In this study, we investigated the effects and underlying mechanisms of action of cnidium lactone on receptor activator of NF-κB ligand (RANKL)-induced osteoclastogenesis. Cnidium lactone dose-dependently inhibited osteoclast differentiation and formation, decreased the bone-resorbing activity of osteoclasts, and downregulated the expression of osteoclast differentiation marker genes. Cnidium lactone treatment considerably reduced RANKL-induced p38 MAPK and PI3K-Akt signal activity in RAW264.7 cells. The cnidium lactone-induced osteoclastogenesis was significantly attenuated by inhibition of p38 and PI3K through pretreatment with SB203580 and LY294002, respectively. Furthermore, cnidium lactone inhibited the expression of c-Fos and NFATc-1 with dose-dependently and enhanced by SB203580 and LY294002. In conclusion, cnidium lactone inhibits osteoclast differentiation through p38 MAPK and PI3K-Akt signalling pathway/c-Fos/NFATc1 signalling pathway.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Bone Metabolism and Diseases · Bone health and treatments · Bone health and osteoporosis research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Second Area of Spinal Surgery, Weihaiwei People’s Hospital
Department of Orthopedics, Qilu Hospital of Shandong University
References (19)
Show source-provided references
1. 10.1016/j.freeradbiomed.2018.08.03610.1016/j.freeradbiomed.2018.08.036 ↗
2. 10.12659/MSM.90965110.12659/MSM.909651 ↗
3. 10.1002/jbmr.24210.1002/jbmr.242 ↗
4. 10.1016/j.biocel.2012.04.00310.1016/j.biocel.2012.04.003 ↗
5. 10.1615/CritRevEukaryotGeneExpr.201802127510.1615/CritRevEukaryotGeneExpr.2018021275 ↗
6. 10.1016/j.jsbmb.2013.09.00810.1016/j.jsbmb.2013.09.008 ↗
7. 10.1016/j.biopha.2017.02.07310.1016/j.biopha.2017.02.073 ↗
8. 10.1248/bpb.25.73810.1248/bpb.25.738 ↗
9. 10.1016/j.bone.2014.07.00310.1016/j.bone.2014.07.003 ↗
10. 10.1074/jbc.M60972320010.1074/jbc.M609723200 ↗
11. 10.1016/j.cbi.2018.03.00210.1016/j.cbi.2018.03.002 ↗
12. 10.1016/j.cellsig.2013.02.01510.1016/j.cellsig.2013.02.015 ↗
13. 10.1016/j.bbrc.2014.08.11710.1016/j.bbrc.2014.08.117 ↗
14. 10.1097/GME.000000000000115010.1097/GME.0000000000001150 ↗
15. 10.1016/S8756-3282(01)00657-310.1016/S8756-3282(01)00657-3 ↗
16. 10.4049/jimmunol.110125410.4049/jimmunol.1101254 ↗
17. 10.1007/s00418-018-1636-210.1007/s00418-018-1636-2 ↗
18. 10.1242/jcs.0331010.1242/jcs.03310 ↗
19. 10.1007/978-1-4939-0805-9_1410.1007/978-1-4939-0805-9_14 ↗